The Buy-side Backlog

Automation

The tremendous growth in OTC derivatives is driving increased spending in automation of reference data, with rapidly scaling businesses struggling to deal with data management. The expansion presents challenges to both buy-side and sell-side institutions, but the barriers to be overcome tend to be different.

Having invested heavily in automation of OTC derivatives in recent years, larger sell-side institutions focused on creating strong infrastructures are in a different phase of the data man

To continue reading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: